MS research suggests the disease may be divided into two biological subtypes that differ in how early and aggressively nerve ...

There may be two distinct subtypes of multiple sclerosis, according to a new study led by scientists at University College ...

Artificial intelligence (AI), using a simple blood test combined with standard brain images has, for the first time, been ...

For the first time, UCL researchers have used AI to identify two biologically distinct forms of multiple sclerosis ...

"We plan to analyze these MRI structural measures longitudinally to determine if changes in brain volumes or lesion burden over time contribute to fatigue trajectories. More broadly, we might ...

The ratio between two signaling molecules may be a key marker of MS brain inflammation and help identify candidates for BTK ...

NIH study reveals key players underlying disease onset and repair. Using an animal model of multiple sclerosis (MS), researchers at the National Institutes of Health (NIH) have created a ...

MS is currently treated with 'disease-modifying' medicines (e.g. interferon beta, glatiramer acetate, natalizumab, fingolimod, alemtuzumab, teriflunomide, and dimethyl fumarate). These medicines can ...

Changes in NAWM and NAGM are crucial in MS progression, challenging the traditional lesion-centric model. Subtle alterations in myelin integrity, immune cell function, and neuronal connectivity ...